Jahn M. Nesland

Publications published between 1980 and 2009 or in press by Jahn Marthin Nesland

456 publications found

Publications in press

1. Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K
   Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies
   BJU Int (in press)
   PubMed 22093091
2. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O
   B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
   Int J Cancer (in press)
   PubMed 22473715
3. Liu Y, Vlatkovic L, Saeter T, Servoll E, Waaler G, Nesland JM, Giercksky KE, Axcrona K
   Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
   Int J Urol (in press)
   PubMed 22487487
4. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z
   Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
   Tumour Biol (in press)
   PubMed 22252524

Publications 2009

1. Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB (2009)
   Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
   Histopathology, 54 (3), 355-64
   PubMed 19236512
2. Bassarova A, Trøen G, Fosså A, Ikonomou IM, Beiske K, Nesland JM, Delabie J (2009)
   Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation
   J Hematop, 2 (3), 135-41
   PubMed 19669194
3. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
   Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
   Histol Histopathol, 24 (8), 1049-59
   PubMed 19554512
4. Goscinski MA, Larsen SG, Warloe T, Stoldt S, Nesland JM, Suo ZH, Giercksky KE (2009)
   Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?
   Scand J Surg, 98 (4), 214-20
   PubMed 20218417
5. He W, Wang Z, Wang Q, Fan Q, Shou C, Wang J, Giercksky KE, Nesland JM, Suo Z (2009)
   Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis
   BMC Cancer, 9, 426
   PubMed 19995427
6. Holm R, Ali T, Svendsrud DH, Nesland JM, Kristensen GB, Lyng H (2009)
   Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome
   Oncol Rep, 22 (1), 11-5
   PubMed 19513498
7. Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B (2009)
   Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma
   Hum Pathol, 40 (6), 795-806
   PubMed 19157506
8. Knopp S, Tropè C, Nesland JM, Holm R (2009)
   A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice
   J Clin Pathol, 62 (3), 212-8
   PubMed 19251952
9. Konstantinovsky S, Smith Y, Zilber S, Tuft Stavnes H, Becker AM, Nesland JM, Reich R, Davidson B (2009)
   Breast carcinoma cells in primary tumors and effusions have different gene array profiles
   J Oncol, 2010, 969084
   PubMed 19680458
10. Lü X, Li H, Xu K, Nesland JM, Suo Z (2009)
    MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells
    Histol Histopathol, 24 (11), 1381-90
    PubMed 19760587
11. Wang Q, He W, Lu C, Wang Z, Wang J, Giercksky KE, Nesland JM, Suo Z (2009)
    Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma
    Anticancer Res, 29 (4), 1233-41
    PubMed 19414369
12. Yuan Y, Nymoen DA, Stavnes HT, Rosnes AK, Bjørang O, Wu C, Nesland JM, Davidson B (2009)
    Tenascin-X is a novel diagnostic marker of malignant mesothelioma
    Am J Surg Pathol, 33 (11), 1673-82
    PubMed 19738457

Publications 2008

1. Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W (2008)
   Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
   Prostate, 68 (15), 1607-14
   PubMed 18655095
2. Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL (2008)
   Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
   J Pathol, 214 (3), 357-67
   PubMed 18044827
3. Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, Småstuen MC, Fosså SD, Saeter G (2008)
   Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
   Acta Oncol, 47 (8), 1475-82
   PubMed 18607853
4. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
   Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
   Clin Cancer Res, 14 (8), 2341-50
   PubMed 18413823
5. Dong HP, Kleinberg L, Silins I, Flørenes VA, Tropé CG, Risberg B, Nesland JM, Davidson B (2008)
   Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma
   Cancer, 112 (1), 84-93
   PubMed 17985388
6. Goscinski MA, Suo Z, Flørenes VA, Vlatkovic L, Nesland JM, Giercksky KE (2008)
   FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions
   Ultrastruct Pathol, 32 (3), 89-96
   PubMed 18570153
7. Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE (2008)
   Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China
   Oncology, 75 (1-2), 49-59
   PubMed 18787344
8. Goscinski MA, Suo ZH, Nesland JM, Flørenes VA, Giercksky KE (2008)
   Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines
   APMIS, 116 (9), 823-31
   PubMed 19024603
9. Holm R, Knopp S, Kumar R, Lee J, Nesland JM, Tropè C, Callen DF (2008)
   Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis
   J Clin Pathol, 61 (1), 59-63
   PubMed 17468294
10. Kleinberg L, Pradhan M, Tropé CG, Nesland JM, Davidson B, Risberg B (2008)
    Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors
    Diagn Cytopathol, 36 (9), 637-44
    PubMed 18677760
11. Knopp S, Nesland JM, Tropé C (2008)
    SLNB and the importance of micrometastases in vulvar squamous cell carcinoma
    Surg Oncol, 17 (3), 219-25
    PubMed 18556194
12. Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM, Holm R (2008)
    The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
    BMC Cancer, 8, 308
    PubMed 18950492

Publications 2007

1. Bartkova J, Horejsí Z, Sehested M, Nesland JM, Rajpert-De Meyts E, Skakkebaek NE, Stucki M, Jackson S, Lukas J, Bartek J (2007)
   DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours
   Oncogene, 26 (53), 7414-22
   PubMed 17546051
2. Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G (2007)
   Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
   Int J Cancer, 120 (8), 1603-9
   PubMed 17230512
3. Cunderlíková B, Wahlqvist R, Berner A, Vasovic V, Warloe T, Nesland JM, Peng Q (2007)
   Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples
   Cytopathology, 18 (2), 87-95
   PubMed 17397493
4. Holm R, Knopp S, Suo Z, Tropè C, Nesland JM (2007)
   Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis
   J Clin Pathol, 60 (10), 1086-91
   PubMed 17158642
5. Khouja MH, Baekelandt M, Nesland JM, Holm R (2007)
   The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma
   Int J Gynecol Pathol, 26 (4), 418-25
   PubMed 17885492
6. Kleinberg L, Flørenes VA, Nesland JM, Davidson B (2007)
   Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions
   Am J Clin Pathol, 128 (3), 389-97
   PubMed 17709312
7. Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B (2007)
   Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
   Cancer, 109 (2), 228-38
   PubMed 17167759
8. Kleinberg L, Lie AK, Flørenes VA, Nesland JM, Davidson B (2007)
   Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma
   Hum Pathol, 38 (7), 986-94
   PubMed 17350081
9. Kleivi K, Lind GE, Diep CB, Meling GI, Brandal LT, Nesland JM, Myklebost O, Rognum TO, Giercksky KE, Skotheim RI, Lothe RA (2007)
   Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
   Mol Cancer, 6, 2
   PubMed 17201907
10. Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS (2007)
    TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
    Breast Cancer Res, 9 (3), R30
    PubMed 17504517
11. Langseth H, Johansen BV, Nesland JM, Kjaerheim K (2007)
    Asbestos fibers in ovarian tissue from Norwegian pulp and paper workers
    Int J Gynecol Cancer, 17 (1), 44-9
    PubMed 17291230
12. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
    Mol Oncol, 1 (2), 160-71
    PubMed 19383292
13. Paulsen T, Ree AH, Kaern J, Kjaerheim K, Bassarova A, Berner A, Haldorsen T, Tropé C, Nesland JM (2007)
    Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation
    Eur J Gynaecol Oncol, 28 (5), 356-63
    PubMed 17966213
14. Røtterud R, Fosså SD, Nesland JM (2007)
    Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
    Histol Histopathol, 22 (4), 349-63
    PubMed 17290345
15. Sudbo J, Ristimaki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M (2007)
    Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions (Retraction of vol 39, pg 497, 2003)
    Oral Oncol., 43 (4), 420
16. Wu Q, Lind GE, Aasheim HC, Micci F, Silins I, Tropé CG, Nesland JM, Lothe RA, Suo Z (2007)
    The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers
    Epigenetics, 2 (4), 237-43
    PubMed 18281782
17. Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE (2007)
    DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
    Mol Cancer, 6, 45
    PubMed 17623056
18. Zhang MZ, Qiao YH, Nesland JM, Trope C, Kennedy A, Chen WT, Suo ZH (2007)
    Expression of seprase in effusions from patients with epithelial ovarian carcinoma
    Chin Med J (Engl), 120 (8), 663-8
    PubMed 17517181

Publications 2006

1. Aghmesheh M, Suo Z, Friedlander M, Nesland JM, Kaern J, Stewart M, Kconfab, Dorum A, Tucker KM, Buckley MF (2006)
   Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas
   Pathology, 38 (2), 145-51
   PubMed 16680901
2. Amarzguioui M, Peng Q, Wiiger MT, Vasovic V, Babaie E, Holen T, Nesland JM, Prydz H (2006)
   Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells
   Clin Cancer Res, 12 (13), 4055-61
   PubMed 16818705
3. Bassarova AV, Nesland JM, Davidson B (2006)
   D2-40 is not a specific marker for cells of mesothelial origin in serous effusions
   Am J Surg Pathol, 30 (7), 878-82
   PubMed 16819331
4. Bondi J, Bukholm G, Nesland JM, Bakka A, Bukholm IR (2006)
   An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients
   Int J Colorectal Dis, 21 (3), 231-7
   PubMed 15937692
5. Borgen E, Pantel K, Schlimok G, Müller P, Otte M, Renolen A, Ehnle S, Coith C, Nesland JM, Naume B (2006)
   A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow
   Cytometry B Clin Cytom, 70 (6), 400-9
   PubMed 16924637
6. Bukholm IR, Nesland JM, Bukholm G (2006)
   Expression of adhesion proteins E-cadherin, alpha-catenin, beta-catenin and gamma-catenin is different in T1 and T2 breast tumours
   Pathology, 38 (5), 403-7
   PubMed 17008277
7. Chen D, Kennedy A, Wang JY, Zeng W, Zhao Q, Pearl M, Zhang M, Suo Z, Nesland JM, Qiao Y, Ng AK, Hirashima N, Yamane T, Mori Y, Mitsumata M, Ghersi G, Chen WT (2006)
   Activation of EDTA-resistant gelatinases in malignant human tumors
   Cancer Res, 66 (20), 9977-85
   PubMed 17047060
8. Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R (2006)
   The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma
   Gynecol Oncol, 102 (3), 453-61
   PubMed 16494928
9. Drageset V, Nesland JM, Erikstein B, Skovlund E, Sommer H, Anker G, Wist E, Lundgren S, Bergh J, Kvalheim G (2006)
   Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
   Int J Cancer, 118 (11), 2877-81
   PubMed 16381016
10. Furre IE, Møller MT, Shahzidi S, Nesland JM, Peng Q (2006)
    Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells
    Apoptosis, 11 (11), 2031-42
    PubMed 17036199
11. Godal A, Nilsen NO, Klaveness J, Branden JE, Nesland JM, Peng Q (2006)
    New derivatives of 5-aminolevulinic acid for photodynamic therapy: chemical synthesis and porphyrin production in in vitro and in vivo biological systems
    J Environ Pathol Toxicol Oncol, 25 (1-2), 109-26
    PubMed 16566712
12. Helland A, Johnsen H, Frøyland C, Landmark HB, Saetersdal AB, Holmen MM, Gjertsen T, Nesland JM, Ottestad W, Jeffrey SS, Ottestad LO, Rodningen OK, Sherlock G, Børresen-Dale AL (2006)
    Radiation-induced effects on gene expression: an in vivo study on breast cancer
    Radiother Oncol, 80 (2), 230-5
    PubMed 16890317
13. Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, Peng Q (2006)
    Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy
    Cancer Lett, 244 (2), 182-9
    PubMed 16427735
14. Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q (2006)
    Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines
    J Photochem Photobiol B, 84 (3), 213-20
    PubMed 16709459
15. Kleinberg L, Flørenes VA, Skrede M, Dong HP, Nielsen S, McMaster MT, Nesland JM, Shih IeM, Davidson B (2006)
    Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma
    Virchows Arch, 449 (1), 31-9
    PubMed 16541284
16. Knopp S, Holm R, Bjørge T, Tropé C, Nesland JM (2006)
    Cell cycle regulation in primary vulvar carcinomas and related lymph node metastases
    Histopathology, 49 (3), 311-2
    PubMed 16918980
17. Knopp S, Nesland JM, Tropé C, Holm R (2006)
    p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma
    Am J Clin Pathol, 126 (2), 266-76
    PubMed 16891203
18. Lazarova P, Wu Q, Kvalheim G, Suo Z, Haakenstad KW, Metodiev K, Nesland JM (2006)
    Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood
    Int J Immunopathol Pharmacol, 19 (1), 49-56
    PubMed 16569339
19. Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC (2006)
    Metaplastic breast carcinomas are basal-like tumours
    Histopathology, 49 (1), 10-21
    PubMed 16842242
20. Shahzidi S, Stokke T, Soltani H, Nesland JM, Peng Q (2006)
    Induction of apoptosis by hexaminolevulinate-mediated photodynamic therapy in human colon carcinoma cell line 320DM
    J Environ Pathol Toxicol Oncol, 25 (1-2), 159-71
    PubMed 16566715
21. Steffensen IL, Schut HA, Nesland JM, Tanaka K, Alexander J (2006)
    Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice
    Mutat Res, 611 (1-2), 71-82
    PubMed 16962818
22. Wiedswang G, Borgen E, Schirmer C, Kåresen R, Kvalheim G, Nesland JM, Naume B (2006)
    Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer
    Int J Cancer, 118 (8), 2013-9
    PubMed 16287086
23. Wu Q, Suo Z, Kristensen GB, Baekelandt M, Nesland JM (2006)
    The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma
    Gynecol Oncol, 102 (1), 15-21
    PubMed 16499955

Publications 2005

1. Bartkova J, Horejsí Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Ørntoft T, Lukas J, Bartek J (2005)
   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
   Nature, 434 (7035), 864-70
   PubMed 15829956
2. Bassarova AV, Nesland JM, Sedloev T, Lilleby W, Hristova SL, Trifonov DY, Torlakovic E (2005)
   Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53
   Int J Surg Pathol, 13 (3), 239-46
   PubMed 16086078
3. Bassarova AV, Torlakovic E, Sedloev T, Hristova SL, Trifonov DV, Nesland JM (2005)
   Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile
   Histol Histopathol, 20 (3), 791-9
   PubMed 15944928
4. Bondi J, Husdal A, Bukholm G, Nesland JM, Bakka A, Bukholm IR (2005)
   Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome
   J Clin Pathol, 58 (5), 509-14
   PubMed 15858123
5. Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B (2005)
   Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
   Cancer, 103 (8), 1631-43
   PubMed 15742334
6. Furre IE, Shahzidi S, Luksiene Z, Møller MT, Borgen E, Morgan J, Tkacz-Stachowska K, Nesland JM, Peng Q (2005)
   Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells
   Cancer Res, 65 (23), 11051-60
   PubMed 16322255
7. Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z (2005)
   The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas
   Gynecol Oncol, 99 (2), 278-86
   PubMed 16061279
8. Kaern J, Aghmesheh M, Nesland JM, Danielsen HE, Sandstad B, Friedlander M, Tropé C (2005)
   Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?
   Int J Gynecol Cancer, 15 (6), 1014-22
   PubMed 16343177
9. Kildal W, Risberg B, Abeler VM, Kristensen GB, Sudbø J, Nesland JM, Danielsen HE (2005)
   beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients
   Eur J Cancer, 41 (8), 1127-34
   PubMed 15911235
10. Knopp S, Bjørge T, Nesland JM, Tropé C, Holm R (2005)
    Cyclins D1, D3, E, and A in vulvar carcinoma patients
    Gynecol Oncol, 97 (3), 733-9
    PubMed 15894358
11. Knopp S, Holm R, Tropé C, Nesland JM (2005)
    Occult lymph node metastases in early stage vulvar carcinoma patients
    Gynecol Oncol, 99 (2), 383-7
    PubMed 16051338
12. Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B (2005)
    Angiogenic molecule expression is downregulated in effusions from breast cancer patients
    Breast Cancer Res Treat, 94 (1), 71-80
    PubMed 16142438
13. Kringen P, Bergamaschi A, Due EU, Wang Y, Tagliabue E, Nesland JM, Nehman A, Tönisson N, Børresen-Dale AL (2005)
    Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas
    Biotechniques, 39 (5), 755-61
    PubMed 16312222
14. Kringen P, Wang Y, Dumeaux V, Nesland JM, Kristensen G, Borresen-Dale AL, Dorum A (2005)
    TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
    BMC Cancer, 5, 134
    PubMed 16229746
15. Reis-Filho JS, Milanezi F, Carvalho S, Simpson PT, Steele D, Savage K, Lambros MB, Pereira EM, Nesland JM, Lakhani SR, Schmitt FC (2005)
    Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
    Breast Cancer Res, 7 (6), R1028-35
    PubMed 16280056
16. Røtterud R, Nesland JM, Berner A, Fosså SD (2005)
    Expression of the epidermal growth factor receptor family in normal and malignant urothelium
    BJU Int, 95 (9), 1344-50
    PubMed 15892828
17. Schaner ME, Davidson B, Skrede M, Reich R, Flørenes VA, Risberg B, Berner A, Goldberg I, Givant-Horwitz V, Tropè CG, Kristensen GB, Nesland JM, Børresen-Dale AL (2005)
    Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
    Mol Cancer, 4, 26
    PubMed 16042759
18. Shi HR, Wu QH, Suo ZH, Nesland JM (2005)
    [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer]
    Ai Zheng, 24 (1), 7-11
    PubMed 15642192
19. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA (2005)
    Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
    Cancer Res, 65 (13), 5588-98
    PubMed 15994931
20. Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J (2005)
    PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor
    J Pathol, 206 (3), 312-9
    PubMed 15892171
21. Torlakovic G, Torlakovic E, Skovlund E, Nesland JM, Reith A, Danielsen HE (2005)
    Volume-related sequence of tumor distribution pattern in prostate carcinoma: importance of posterior midline crossover in predicting tumor volume, extracapsular extension, and seminal vesicle invasion
    Croat Med J, 46 (3), 429-35
    PubMed 15861523
22. Wang Y, Kristensen GB, Helland A, Nesland JM, Børresen-Dale AL, Holm R (2005)
    Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas
    Am J Clin Pathol, 124 (3), 392-401
    PubMed 16191507
23. Xu F, Zhong W, Li J, Shanshen Z, Cui J, Nesland JM, Suo Z (2005)
    Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma
    Anticancer Res, 25 (4), 2943-50
    PubMed 16080548

Publications 2004

1. Aghmesheh M, Nesland JM, Kaern J, Dorum A, Edwards L, Byth K, Friedlander M, Jackson P, Tucker KM, Russell PJ (2004)
   No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers
   Gynecol Oncol, 95 (3), 430-6
   PubMed 15581943
2. Andersen K, Nesland JM, Holm R, Flørenes VA, Fodstad Ø, Maelandsmo GM (2004)
   Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma
   Mod Pathol, 17 (8), 990-7
   PubMed 15133476
3. Bassarova A, Nesland JM, Sedloev T, Danielsen H, Christova S (2004)
   Pilomatrix carcinoma with lymph node metastases
   J Cutan Pathol, 31 (4), 330-5
   PubMed 15005691
4. Bilalovic N, Blystad AK, Golouh R, Nesland JM, Selak I, Trinh D, Torlakovic E (2004)
   Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma
   Am J Clin Pathol, 121 (1), 34-42
   PubMed 14750238
5. Bilalovic N, Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE (2004)
   CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression
   Mod Pathol, 17 (10), 1251-8
   PubMed 15205682
6. Bondi J, Bukholm G, Nesland JM, Bukholm IR (2004)
   Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas
   APMIS, 112 (1), 49-56
   PubMed 14961975
7. Davidson B, Reich R, Lazarovici P, Ann Flørenes V, Nielsen S, Nesland JM (2004)
   Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma
   Breast Cancer Res Treat, 83 (2), 119-28
   PubMed 14997042
8. Davidson B, Suo Z, Nesland JM (2004)
   Malignant mesothelioma
   Ultrastruct Pathol, 28 (4), 179-80
   PubMed 15693629
9. Diep CB, Teixeira MR, Thorstensen L, Wiig JN, Eknaes M, Nesland JM, Giercksky KE, Johansson B, Lothe RA (2004)
   Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients
   Mol Cancer, 3, 6
   PubMed 14977426
10. Flørenes VA, Skrede M, Jørgensen K, Nesland JM (2004)
    Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival
    Melanoma Res, 14 (3), 173-81
    PubMed 15179185
11. Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R (2004)
    The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma
    Gynecol Oncol, 93 (2), 517-23
    PubMed 15099972
12. Hernes E, Fosså SD, Berner A, Otnes B, Nesland JM (2004)
    Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
    Br J Cancer, 90 (2), 449-54
    PubMed 14735192
13. Knopp S, Bjørge T, Nesland JM, Tropé C, Scheistrøen M, Holm R (2004)
    p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas
    Gynecol Oncol, 95 (1), 37-45
    PubMed 15385108
14. Lazarova P, Lijun M, Hammerstad H, Nesland J, Gaudernack G, Kvalheim G (2004)
    Experimental attempt to introduce a vaccine therapy by using DC-developed from CD34+cells
    NATO SCI SER I LIFE, 361, 134
15. Li H, Suo Z, Zhang Y, Risberg B, Karlsson MG, Villman K, Nesland JM (2004)
    The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas
    Histol Histopathol, 19 (1), 129-36
    PubMed 14702180
16. Li HX, Zh S, Zhang YH, Risberg B, Karlsson MG, Nesland JM (2004)
    [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis]
    Zhonghua Zhong Liu Za Zhi, 26 (11), 669-72
    PubMed 15777505
17. Lindboe CF, Matre J, Nesland JM (2004)
    Adenoma of the esophagus with intracytoplasmic mucoid bodies
    APMIS, 112 (1), 29-33
    PubMed 14961971
18. Naume B, Borgen E, Tøssvik S, Pavlak N, Oates D, Nesland JM (2004)
    Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method
    Cytotherapy, 6 (3), 244-52
    PubMed 15203981
19. Naume B, Wiedswang G, Borgen E, Kvalheim G, Kåresen R, Qvist H, Janbu J, Harbitz T, Nesland JM (2004)
    The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells
    Clin Cancer Res, 10 (9), 3091-7
    PubMed 15131048
20. Nesland JM (2004)
    Ultrastructural examination and technical developments
    Ultrastruct Pathol, 28 (1), 1
    PubMed 14967592
21. Nesland JM (2004)
    Ultrastructural and molecular analysis of cribriform-morular variant of papillary thyroid carcinoma
    Ultrastruct Pathol, 28 (2), 53
    PubMed 15205104
22. Nesland JM (2004)
    Chronic cholecystitis
    Ultrastruct Pathol, 28 (3), 121
    PubMed 15471424
23. Peng Q, Nesland JM (2004)
    Effects of photodynamic therapy on tumor stroma
    Ultrastruct Pathol, 28 (5-6), 333-40
    PubMed 15764581
24. Reed W, Bøhler PJ, Sandstad B, Nesland JM (2004)
    Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up
    Breast J, 10 (3), 174-80
    PubMed 15125740
25. Suo Z, Daehli KU, Lindboe CF, Borgen E, Bassarova A, Nesland JM (2004)
    Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients
    Int J Surg Pathol, 12 (4), 311-8
    PubMed 15494857
26. Suo Z, Karbovo E, Trope CG, Metodiev K, Nesland JM (2004)
    Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study
    Ultrastruct Pathol, 28 (3), 141-7
    PubMed 15471427
27. Torlakovic EE, Bilalovic N, Nesland JM, Torlakovic G, Flørenes VA (2004)
    Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis
    Mod Pathol, 17 (11), 1400-6
    PubMed 15205685
28. Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A (2004)
    Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma
    Hum Mutat, 24 (1), 21-34
    PubMed 15221786
29. Wiedswang G, Borgen E, Kåresen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B (2004)
    Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome
    Clin Cancer Res, 10 (16), 5342-8
    PubMed 15328170
30. Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z (2004)
    Prognostic significance of dysadherin expression in cervical squamous cell carcinoma
    Pathol Oncol Res, 10 (4), 212-8
    PubMed 15619642
31. Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM (2004)
    Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma
    Gynecol Oncol, 94 (2), 312-9
    PubMed 15297167
32. Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K, Nesland JM (2004)
    Expression of Ephb2 and Ephb4 in breast carcinoma
    Pathol Oncol Res, 10 (1), 26-33
    PubMed 15029258
33. Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS (2004)
    Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
    Mol Biol Cell, 15 (6), 2523-36
    PubMed 15034139

Publications 2003

1. Berner HS, Suo Z, Risberg B, Villman K, Karlsson MG, Nesland JM (2003)
   Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas
   Histopathology, 42 (6), 546-54
   PubMed 12786890
2. Bukholm IR, Bondi J, Wiik P, Nesland JM, Andersen SN, Bakka A, Bukholm G (2003)
   Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer
   Eur J Surg Oncol, 29 (10), 862-6
   PubMed 14624779
3. Bukholm IR, Bukholm G, Holm R, Nesland JM (2003)
   Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas
   J Clin Pathol, 56 (5), 368-73
   PubMed 12719458
4. Bukholm IR, Husdal A, Nesland JM, Langerød A, Bukholm G (2003)
   Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time
   Breast Cancer Res Treat, 80 (2), 199-206
   PubMed 12908823
5. Davidson B, Givant-Horwitz V, Lazarovici P, Risberg B, Nesland JM, Trope CG, Schaefer E, Reich R (2003)
   Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma
   Clin Exp Metastasis, 20 (7), 621-31
   PubMed 14669793
6. Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA (2003)
   Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma
   Clin Cancer Res, 9 (6), 2248-59
   PubMed 12796393
7. Diep CB, Parada LA, Teixeira MR, Eknaes M, Nesland JM, Johansson B, Lothe RA (2003)
   Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis
   Genes Chromosomes Cancer, 36 (2), 189-97
   PubMed 12508247
8. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM (2003)
   Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer
   J Pathol, 200 (5), 589-95
   PubMed 12898594
9. Fosså SD, Aass N, Heilo A, Daugaard G, E Skakkebaek N, Stenwig AE, Nesland JM, Looijenga LH, Oosterhuis JW (2003)
   Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy
   Ann Oncol, 14 (9), 1412-8
   PubMed 12954581
10. Givant-Horwitz V, Davidson B, Lazarovici P, Schaefer E, Nesland JM, Tropé CG, Reich R (2003)
    Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions
    Gynecol Oncol, 91 (1), 160-72
    PubMed 14529677
11. Hjortland GO, Bjørnland K, Pettersen S, Garman-Vik SS, Emilsen E, Nesland JM, Fodstad O, Engebraaten O (2003)
    Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1
    Clin Exp Metastasis, 20 (4), 301-9
    PubMed 12856717
12. Ikonomou IM, Nesland JM, Schjølseth SA, Heim S, Delabie J (2003)
    Mantle cell lymphoma with Homer-Wright rosettes
    Virchows Arch, 442 (2), 179-82
    PubMed 12596071
13. Lilleby W, Nesland JM, Fosså SD, Torlakovic G, Waehre H, Kvalheim G (2003)
    The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
    Int J Cancer, 103 (1), 91-6
    PubMed 12455058
14. Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, Fosså SD, Oosterhuis JW (2003)
    Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors
    Cancer Res, 63 (22), 7674-8
    PubMed 14633689
15. Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA (2003)
    Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma
    Clin Cancer Res, 9 (9), 3383-8
    PubMed 12960126
16. Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland JM (2003)
    Pregnancy and breast cancer: a population-based study
    Virchows Arch, 443 (1), 44-50
    PubMed 12756565
17. Reed W, Sandstad B, Holm R, Nesland JM (2003)
    The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators
    Int J Surg Pathol, 11 (2), 65-74
    PubMed 12754622
18. Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA (2003)
    Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
    Neoplasia, 5 (5), 397-404
    PubMed 14670177
19. Skotheim RI, Kallioniemi A, Bjerkhagen B, Mertens F, Brekke HR, Monni O, Mousses S, Mandahl N, Soeter G, Nesland JM, Smeland S, Kallioniemi OP, Lothe RA (2003)
    Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome
    J Clin Oncol, 21 (24), 4586-91
    PubMed 14673046
20. Skotheim RI, Korkmaz KS, Klokk TI, Abeler VM, Korkmaz CG, Nesland JM, Fosså SD, Lothe RA, Saatcioglu F (2003)
    NKX3.1 expression is lost in testicular germ cell tumors
    Am J Pathol, 163 (6), 2149-54
    PubMed 14633588
21. Sudbø J, Reith A, Flørenes VA, Nesland JM, Ristimäki A, Bryne M (2003)
    COX-2 expression in striated muscle under physiological conditions
    Oral Dis, 9 (6), 313-6
    PubMed 14629333
22. Sudbø J, Ristimäki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M (2003)
    Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions
    Oral Oncol, 39 (5), 497-505 (Retracted)
    PubMed 12747975
23. Suo Z, Nesland JM (2003)
    Electron microscopy in diagnosis of spindle cell tumors
    Semin Diagn Pathol, 20 (1), 5-12
    PubMed 12693671
24. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM (2003)
    Morphologic reappraisal of serrated colorectal polyps
    Am J Surg Pathol, 27 (1), 65-81
    PubMed 12502929
25. Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B (2003)
    Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
    J Clin Oncol, 21 (18), 3469-78
    PubMed 12972522
26. Wu Q, Shi H, Suo Z, Nesland JM (2003)
    5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas
    Ultrastruct Pathol, 27 (6), 417-22
    PubMed 14660280

Publications 2002

1. Bassarova AV, Sedloev T, Christova SL, Trifonov DY, Nesland JM (2002)
   Invasive lobular carcinoma in a hypoplastic breast
   Ultrastruct Pathol, 26 (6), 411-4
   PubMed 12537766
2. Bukholm IR, Bukholm G, Nesland JM (2002)
   Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas
   APMIS, 110 (3), 214-20
   PubMed 12076274
3. Davidson B, Goldberg I, Givant-Horwitz V, Nesland JM, Berner A, Bryne M, Risberg B, Kopolovic J, Kristensen GB, Tropé CG, van de Putte G, Reich R (2002)
   Caveolin-1 expression in ovarian carcinoma is MDR1 independent
   Am J Clin Pathol, 117 (2), 225-34
   PubMed 11863219
4. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Reich R (2002)
   The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma
   Mol Cell Endocrinol, 187 (1-2), 39-45
   PubMed 11988310
5. Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I (2002)
   Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions
   Clin Exp Metastasis, 19 (2), 135-44
   PubMed 11964077
6. Davidson B, Reich R, Risberg B, Nesland JM (2002)
   The biological role and regulation of matrix metalloproteinases (MMP) in cancer
   Arkh Patol, 64 (3), 47-53
   PubMed 15338725
7. Eyden B, Banerjee SS, Nesland JM (2002)
   Amphicrine carcinoma of breast with giant granules: an immunohistochemical, histochemical and ultrastructural study
   J Submicrosc Cytol Pathol, 34 (1), 27-36
   PubMed 11989854
8. Friesen SA, Hjortland GO, Madsen SJ, Hirschberg H, Engebraten O, Nesland JM, Peng Q (2002)
   5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review)
   Int J Oncol, 21 (3), 577-82
   PubMed 12168102
9. Johannessen HO, Dale E, Hellebust TP, Olsen DR, Nesland JM, Giercksky KE (2002)
   Modeling volume effects of experimental brachytherapy in the rat rectum: uncovering the limitations of a radiobiologic concept
   Int J Radiat Oncol Biol Phys, 53 (4), 1014-22
   PubMed 12095571
10. Karbova E, Davidson B, Metodiev K, Tropé CG, Nesland JM (2002)
    Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma
    Int J Surg Pathol, 10 (3), 175-80
    PubMed 12232570
11. Kraggerud SM, Aman P, Holm R, Stenwig AE, Fosså SD, Nesland JM, Lothe RA (2002)
    Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis
    Cancer Res, 62 (2), 512-7
    PubMed 11809703
12. Lopes JM, Nesland JM, Reis-Filho JS, Holm R (2002)
    Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
    Histopathology, 40 (5), 464-71
    PubMed 12010367
13. Lorico A, Nesland J, Emilsen E, Fodstad O, Rappa G (2002)
    Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice
    Toxicology, 171 (2-3), 201-5
    PubMed 11836025
14. Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Flørenes VA, Maelandsmo GM, Serra M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland JM, Knuutila S, Myklebost O (2002)
    Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21
    Oncogene, 21 (14), 2261-9
    PubMed 11948409
15. Pedersen KB, Nesland JM, Fodstad Ø, Maelandsmo GM (2002)
    Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies
    Br J Cancer, 87 (11), 1281-6
    PubMed 12439718
16. Scheistrøen M, Nesland JM, Tropé C (2002)
    Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991
    Eur J Gynaecol Oncol, 23 (2), 93-103
    PubMed 12013120
17. Suo Z, Nesland JM (2002)
    Barrett's esophagus: intestinal metaplasia or phenotypic shift of undifferentiated elements in the stem cells
    Ultrastruct Pathol, 26 (2), 53-4
    PubMed 12036092
18. Suo Z, Nesland JM (2002)
    Type 1 protein tyrosine kinases in breast carcinoma: a review
    Ultrastruct Pathol, 26 (3), 125-35
    PubMed 12184370
19. Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E, Nesland JM (2002)
    EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival
    J Pathol, 196 (1), 17-25
    PubMed 11748637
20. Suo Z, Risberg B, Karlsson MG, Villman K, Skovlund E, Nesland JM (2002)
    The expression of EGFR family ligands in breast carcinomas
    Int J Surg Pathol, 10 (2), 91-9
    PubMed 12075402
21. Yang H, Berner A, Mei Q, Giercksky KE, Warloe T, Yang G, Cui J, Suo Z, Zhang S, Nesland JM (2002)
    Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China
    Acta Cytol, 46 (3), 445-52
    PubMed 12040635

Publications 2001

1. Berner HS, Nesland JM (2001)
   Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast
   Breast Cancer Res Treat, 65 (1), 23-9
   PubMed 11245336
2. Borgen E, Naume B, Nesland JM, Nowels KW, Pavlak N, Ravkin I, Goldbard S (2001)
   Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples
   Cytometry, 46 (4), 215-21
   PubMed 11514954
3. Bukholm IR, Bukholm G, Nesland JM (2001)
   Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas
   Int J Cancer, 93 (2), 283-7
   PubMed 11410878
4. Bukholm IR, Bukholm G, Nesland JM (2001)
   Coexpression of cyclin A and beta-catenin and survival in breast cancer patients
   Int J Cancer, 94 (1), 148-9
   PubMed 11668490
5. Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, Risberg B, Kristensen GB, Tropé CG, Kopolovic J, Reich R (2001)
   Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions
   Am J Clin Pathol, 115 (4), 517-24
   PubMed 11293899
6. Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R (2001)
   Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients
   Clin Cancer Res, 7 (11), 3457-64
   PubMed 11705863
7. Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A, Reich R (2001)
   Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study
   Gynecol Oncol, 81 (2), 166-71
   PubMed 11330944
8. Davidson B, Reich R, Berner A, Givant-Horwitz V, Goldberg I, Risberg B, Kristensen GB, Trope CG, Bryne M, Kopolovic J, Nesland JM (2001)
   Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
   Eur J Cancer, 37 (16), 2040-9
   PubMed 11597382
9. Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM (2001)
   Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma
   Clin Cancer Res, 7 (3), 551-7
   PubMed 11297247
10. Davidson B, Risberg B, Berner A, Nesland JM, Tropé CG, Kristensen GB, Bryne M, Goscinski M, van de Putte G, Flørenes VA (2001)
    Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications
    Gynecol Oncol, 83 (2), 249-56
    PubMed 11606079
11. Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Tropé CG, Kristensen GB, Bryne M, Reich R (2001)
    Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome
    Am J Surg Pathol, 25 (12), 1493-500
    PubMed 11717538
12. Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R (2001)
    Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome
    J Pathol, 195 (5), 530-6
    PubMed 11745687
13. Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, Müller C, Sanvito F, Kononen J, Nesland JM, Fodstad Ø, Reymond A, Kallioniemi OP, Arrigoni G, Ballabio A, Myklebost O, Zollo M (2001)
    Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity
    Oncogene, 20 (47), 6881-90
    PubMed 11687967
14. Goldberg I, Davidson B, Reich R, Gotlieb WH, Ben-Baruch G, Bryne M, Berner A, Nesland JM, Kopolovic J (2001)
    Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma
    Clin Cancer Res, 7 (12), 4073-9
    PubMed 11751504
15. Luksiene Z, Eggen I, Moan J, Nesland JM, Peng Q (2001)
    Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells
    Cancer Lett, 169 (1), 33-9
    PubMed 11410323
16. Naume B, Borgen E, Kvalheim G, Kåresen R, Qvist H, Sauer T, Kumar T, Nesland JM (2001)
    Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics
    Clin Cancer Res, 7 (12), 4122-9
    PubMed 11751511
17. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE (2001)
    Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate
    J Photochem Photobiol B, 62 (3), 140-5
    PubMed 11566277
18. Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM (2001)
    Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts
    Cancer Res, 61 (15), 5824-32
    PubMed 11479222
19. Saeterdal I, Bjørheim J, Lislerud K, Gjertsen MK, Bukholm IK, Olsen OC, Nesland JM, Eriksen JA, Møller M, Lindblom A, Gaudernack G (2001)
    Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
    Proc Natl Acad Sci U S A, 98 (23), 13255-60
    PubMed 11687624
20. Suo Z, Berner HS, Risberg B, Karlsson MG, Nesland JM (2001)
    Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas
    Virchows Arch, 439 (1), 62-9
    PubMed 11499842
21. Suo Z, Bjaamer A, Ottestad L, Nesland JM (2001)
    Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast
    Ultrastruct Pathol, 25 (5), 349-56
    PubMed 11758715
22. Suo Z, Yang H, Mei Q, Skovlund E, Cui J, Nesland JM (2001)
    Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study
    Int J Surg Pathol, 9 (3), 177-87
    PubMed 11584314
23. Thorstensen L, Qvist H, Nesland JM, Giercksky KE, Lothe RA (2001)
    Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas
    Scand J Gastroenterol, 36 (12), 1327-31
    PubMed 11761025

Publications 2000

1. Anvar MD, Khiabani HZ, Nesland JM, Stranden E, Kroese AJ (2000)
   Vascular and stromal features in the skin of the lower limb in patients with chronic critical limb ischaemia (CLI) and oedema
   Eur J Vasc Endovasc Surg, 20 (2), 125-31
   PubMed 10942683
2. Baekelandt M, Holm R, Nesland JM, Tropé CG, Kristensen GB (2000)
   Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer
   J Clin Oncol, 18 (22), 3775-81
   PubMed 11078490
3. Baekelandt MM, Holm R, Nesland JM, Tropé CG, Kristensen GB (2000)
   P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer
   Anticancer Res, 20 (2B), 1061-7
   PubMed 10810398
4. Berner HS, Davidson B, Berner A, Risberg B, Kristensen GB, Trope CG, Van de Putte G, Nesland JM (2000)
   Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications
   Clin Exp Metastasis, 18 (2), 197-202
   PubMed 11235996
5. Berner HS, Davidson B, Berner A, Risberg B, Nesland JM (2000)
   Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions
   Virchows Arch, 436 (4), 330-5
   PubMed 10834535
6. Bironaite D, Nesland JM, Dalen H, Risberg B, Bryne M (2000)
   N-Glycans influence the in vitro adhesive and invasive behaviour of three metastatic cell lines
   Tumour Biol, 21 (3), 165-75
   PubMed 10754467
7. Bukholm IK, Nesland JM (2000)
   Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas
   Virchows Arch, 436 (3), 224-8
   PubMed 10782880
8. Bukholm IK, Nesland JM, Børresen-Dale AL (2000)
   Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]
   J Pathol, 190 (1), 15-9
   PubMed 10640987
9. Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V (2000)
   E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
   J Pathol, 192 (4), 460-9
   PubMed 11113863
10. Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M (2000)
    Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions
    Hum Pathol, 31 (9), 1081-7
    PubMed 11014575
11. Davidson B, Goldberg I, Kopolovic J, Gotlieb WH, Givant-Horwitz V, Nesland JM, Berner A, Ben-Baruch G, Bryne M, Reich R (2000)
    Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study
    Clin Exp Metastasis, 18 (6), 501-7
    PubMed 11592307
12. Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M (2000)
    Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study
    Gynecol Oncol, 77 (1), 35-43
    PubMed 10739688
13. Davidson B, Gotlieb WH, Ben-Baruch G, Nesland JM, Bryne M, Goldberg I, Kopolovic J, Berner A (2000)
    E-Cadherin complex protein expression and survival in ovarian carcinoma
    Gynecol Oncol, 79 (3), 362-71
    PubMed 11104606
14. De Jonge ET, Lindeque BG, Burger W, Nesland JM, Holm R (2000)
    Predicting response to neoadjuvant chemotherapy in patients with cervical carcinoma: can we do without any longer?
    Int J Gynecol Cancer, 10 (2), 137-142
    PubMed 11240665
15. Flørenes VA, Faye RS, Maelandsmo GM, Nesland JM, Holm R (2000)
    Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
    Clin Cancer Res, 6 (9), 3614-20
    PubMed 10999753
16. Giercksky HE, Nesland JM (2000)
    [Microdissection--an important tool in molecular biology]
    Tidsskr Nor Laegeforen, 120 (5), 598-600
    PubMed 10833921
17. Høie J, Heimdal K, Nesland JM, Børmer O (2000)
    [Prophylactic thyroidectomy in carriers of RET oncogene mutation carriers]
    Tidsskr Nor Laegeforen, 120 (27), 3249-52
    PubMed 11187163
18. Knudsen P, Ryther AJ, Nesheim JA, Abeler VM, Nesland JM, Danielsen HE (2000)
    [Telepathology at the Norwegian Radium Hospital]
    Tidsskr Nor Laegeforen, 120 (18), 2170-3
    PubMed 11006741
19. Nesland JM (2000)
    [Pathologic diagnosis--now and in the future]
    Tidsskr Nor Laegeforen, 120 (2), 180
    PubMed 10851909
20. Risberg B, Davidson B, Dong HP, Nesland JM, Berner A (2000)
    Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings
    J Clin Pathol, 53 (7), 513-7
    PubMed 10961174
21. Suo Z, Nesland JM (2000)
    Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features
    Ultrastruct Pathol, 24 (6), 371-81
    PubMed 11206334
22. Thorstensen L, Qvist H, Heim S, Liefers GJ, Nesland JM, Giercksky KE, Lothe RA (2000)
    Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients
    Neoplasia, 2 (6), 514-22
    PubMed 11228544

Publications 1999

1. Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB (1999)
   Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study
   Clin Cancer Res, 5 (10), 2848-53
   PubMed 10537352
2. Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB (1999)
   The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer
   Ann Oncol, 10 (11), 1335-41
   PubMed 10631462
3. Baekelandt M, Kristensen GB, Nesland JM, Tropé CG, Holm R (1999)
   Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer
   J Clin Oncol, 17 (7), 2061
   PubMed 10561259
4. Baekelandt M, Kristensen GB, Tropé CG, Nesland JM, Holm R (1999)
   Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer
   Anticancer Res, 19 (5C), 4469-74
   PubMed 10650794
5. Bjerkehagen B, Dietrich C, Reed W, Micci F, Saeter G, Berner A, Nesland JM, Heim S (1999)
   Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11)
   Virchows Arch, 435 (5), 524-30
   PubMed 10592057
6. Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K (1999)
   Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
   Cytotherapy, 1 (5), 377-88
   PubMed 20426539
7. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Berner A, Bryne M, Reich R (1999)
   High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
   Clin Exp Metastasis, 17 (10), 799-808
   PubMed 11089877
8. De Jonge ET, Viljoen E, Lindeque BG, Amant F, Nesland JM, Holm R (1999)
   The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy
   Int J Gynecol Cancer, 9 (3), 198-205
   PubMed 11240767
9. Hennig EM, Di Lonardo A, Venuti A, Holm R, Marcante ML, Nesland JM (1999)
   HPV 16 in multiple neoplastic lesions in women with CIN III
   J Exp Clin Cancer Res, 18 (3), 369-77
   PubMed 10606184
10. Hennig EM, Kvinnsland S, Holm R, Nesland JM (1999)
    Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas
    Acta Oncol, 38 (7), 931-8
    PubMed 10606422
11. Hennig EM, Nesland JM, Di Lonardo A, Venuti A (1999)
    Multiple primary cancers and HPV infection: are they related?
    J Exp Clin Cancer Res, 18 (1), 53-4
    PubMed 10374677
12. Hennig EM, Suo Z, Karlsen F, Holm R, Thoresen S, Nesland JM (1999)
    HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III)
    Acta Oncol, 38 (5), 639-47
    PubMed 10427955
13. Hennig EM, Suo Z, Thoresen S, Holm R, Kvinnsland S, Nesland JM (1999)
    Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III)
    Breast Cancer Res Treat, 53 (2), 121-35
    PubMed 10326789
14. Jensen P, Nesland JM (1999)
    [Research publication, the faculties, the Tidsskrift]
    Tidsskr Nor Laegeforen, 119 (4), 489
    PubMed 10081369
15. Kvalheim G, Naume B, Nesland JM (1999)
    Minimal residual disease in breast cancer
    Cancer Metastasis Rev, 18 (1), 101-8
    PubMed 10505549
16. Nesland JM (1999)
    [Molecular genetic mechanisms and hereditary disease]
    Tidsskr Nor Laegeforen, 119 (6), 779
    PubMed 10101934
17. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM (1999)
    Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light
    Br J Cancer, 79 (1), 72-81
    PubMed 10408696
18. Reed W, Flørems VA, Holm R, Hannisdal E, Nesland JM (1999)
    Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients
    Virchows Arch, 435 (2), 116-24
    PubMed 10599310
19. Raabe NK, Sauer T, Erichsen A, Nesland JM, Fossaa SD (1999)
    Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer
    Oncol Rep, 6 (5), 1001-7
    PubMed 10425294
20. Scheistrøen M, Tropé C, Pettersen EO, Nesland JM (1999)
    p53 protein expression in squamous cell carcinoma of the vulva
    Cancer, 85 (5), 1133-8
    PubMed 10091798
21. Skomedal H, Kristensen GB, Nesland JM, Børresen-Dale AL, Tropé C, Holm R (1999)
    TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus
    J Pathol, 187 (5), 556-62
    PubMed 10398121
22. van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH (1999)
    Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma
    J Pathol, 189 (4), 504-13
    PubMed 10629550

Publications 1998

1. Borgen E, Beiske K, Trachsel S, Nesland JM, Kvalheim G, Herstad TK, Schlichting E, Qvist H, Naume B (1998)
   Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
   J Pathol, 185 (4), 427-34
   PubMed 9828843
2. Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A (1998)
   The invasive front of carcinomas. The most important area for tumour prognosis?
   Anticancer Res, 18 (6B), 4757-64
   PubMed 9891553
3. Bukholm IK, Berner JM, Nesland JM, Børresen-Dale AL (1998)
   Expression of cyclin Ds in relation to p53 status in human breast carcinomas
   Virchows Arch, 433 (3), 223-8
   PubMed 9769125
4. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1998)
   E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma
   J Pathol, 185 (3), 262-6
   PubMed 9771479
5. Børresen-Dale AL, Lothe RA, Nesland JM (1998)
   [Molecular biology. Basis for increased understanding of diseases and improved diagnostics]
   Tidsskr Nor Laegeforen, 118 (11), 1681
   PubMed 9621751
6. Flørenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM, Holm R (1998)
   Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival
   Am J Pathol, 153 (1), 305-12
   PubMed 9665492
7. Lopes JM, Hannisdal E, Bjerkehagen B, Bruland OS, Danielsen HE, Pettersen EO, Sobrinho-Simões M, Nesland JM (1998)
   Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers
   Anal Cell Pathol, 16 (1), 45-62
   PubMed 9584899
8. Moan J, Peng Q, Sorensen R, Iani V, Nesland JM (1998)
   The biophysical foundations of photodynamic therapy
   Endoscopy, 30 (4), 387-91
   PubMed 9689514
9. Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnås G, Qvist H, Kåresen R, Kvalheim G (1998)
   Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
   Int J Cancer, 78 (5), 556-60
   PubMed 9808522
10. Nedelcheva Kristensen V, Andersen TI, Erikstein B, Geitvik G, Skovlund E, Nesland JM, Børresen-Dale AL (1998)
    Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients
    Pharmacogenetics, 8 (5), 441-7
    PubMed 9825836
11. Noodt BB, Rodal GH, Wainwright M, Peng Q, Horobin R, Nesland JM, Berg K (1998)
    Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells
    Int J Cancer, 75 (6), 941-8
    PubMed 9506541
12. Nordal RR, Kristensen GB, Stenwig AE, Tropé CG, Nesland JM (1998)
    Immunohistochemical analysis of p53 protein in uterine sarcomas
    Gynecol Oncol, 70 (1), 45-8
    PubMed 9698472
13. Suo Z, Emilsen E, Tveit KM, Nesland JM (1998)
    Type 1 protein tyrosine kinases in benign and malignant breast lesions
    Histopathology, 33 (6), 514-21
    PubMed 9870145

Publications 1997

1. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1997)
   Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53
   Int J Cancer, 73 (1), 38-41
   PubMed 9334807
2. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1997)
   Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas
   Virchows Arch, 431 (5), 317-21
   PubMed 9463572
3. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen AL (1997)
   Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas
   J Pathol, 181 (2), 140-5
   PubMed 9120716
4. Fonseca E, Nesland JM, Höie J, Sobrinho-Simões M (1997)
   Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins
   Virchows Arch, 430 (3), 239-45
   PubMed 9099982
5. Fonseca E, Nesland JM, Sobrinho-Simões M (1997)
   Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid
   Histopathology, 31 (4), 330-5
   PubMed 9363448
6. Giercksky HE, Thorstensen L, Qvist H, Nesland JM, Lothe RA (1997)
   Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases
   Diagn Mol Pathol, 6 (6), 318-25
   PubMed 9559291
7. Helland A, Børresen-Dale AL, Peltomäki P, Hektoen M, Kristensen GB, Nesland JM, de la Chapelle A, Lothe RA (1997)
   Microsatellite instability in cervical and endometrial carcinomas
   Int J Cancer, 70 (5), 499-501
   PubMed 9052745
8. Holm R, Flørenes VA, Erikstein B, Nesland JM (1997)
   Expression of stromelysin-3 in medullary carcinoma of the breast
   Anticancer Res, 17 (5B), 3725-7
   PubMed 9427769
9. Kareem BN, Karlsen F, Holm R, Hennig EM, Suo Z, Emilsen E, Hellesylt E, Nesland JM (1997)
   A novel grid polymerase chain reaction (G-PCR) approach at ultrastructural level to detect target DNA in cell cultures and tissues
   J Pathol, 183 (4), 486-93
   PubMed 9496267
10. Lopes JM, Bruland OS, Bjerkehagen B, Silva MC, Holm R, Pettersen EO, Solheim OP, Sobrinho-Simões M, Nesland JM (1997)
    Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance
    Pathol Res Pract, 193 (1), 21-36
    PubMed 9112270
11. Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL (1997)
    Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM
    Genes Chromosomes Cancer, 18 (3), 175-80
    PubMed 9071570
12. Nordal RR, Kristensen GB, Stenwig AE, Nesland JM, Pettersen EO, Trope CG (1997)
    An evaluation of prognostic factors in uterine carcinosarcoma
    Gynecol Oncol, 67 (3), 316-21
    PubMed 9441781
13. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM (1997)
    5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research
    Photochem Photobiol, 65 (2), 235-51
    PubMed 9066303
14. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997)
    5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
    Cancer, 79 (12), 2282-308
    PubMed 9191516
15. Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O (1997)
    High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
    Clin Cancer Res, 3 (9), 1623-8
    PubMed 9815852
16. Scheistrøen M, Tropé C, Kaern J, Pettersen EO, Alfsen GC, Nesland JM (1997)
    DNA ploidy and expression of p53 and C-erbB-2 in extramammary Paget's disease of the vulva
    Gynecol Oncol, 64 (1), 88-92
    PubMed 8995553

Publications 1996

1. Chitemerere M, Andersen TI, Holm R, Karlsen F, Børresen AL, Nesland JM (1996)
   TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast
   Breast Cancer Res Treat, 41 (2), 103-9
   PubMed 8944328
2. Kvalheim G, Pharo A, Holte H, Jakobsen E, Erikstein B, Kvaløy S, Beiske K, Nesland JM, Smeland EB (1996)
   [High-dose therapy of cancer with CD34 positive cells as stem cell support]
   Tidsskr Nor Laegeforen, 116 (21), 2542-6
   PubMed 8928121
3. Lundblad R, Nesland JM, Giercksky KE (1996)
   Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats
   Crit Care Med, 24 (5), 820-6
   PubMed 8706460
4. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM (1996)
   Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX
   Br J Cancer, 74 (1), 22-9
   PubMed 8679453
5. Peng Q, Moan J, Nesland JM (1996)
   Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy
   Ultrastruct Pathol, 20 (2), 109-129
   PubMed 8882357
6. Peng Q, Moan J, Warloe T, Iani V, Steen HB, Bjørseth A, Nesland JM (1996)
   Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin
   J Photochem Photobiol B, 34 (1), 95-6
   PubMed 8765664
7. Thorstensen L, Qvist H, Nesland JM, Giercksky KE, Lothe RA (1996)
   Allelotype profiles of local recurrences and distant metastases from colorectal-cancer patients
   Int J Cancer, 69 (6), 452-6
   PubMed 8980246

Publications 1995

1. Andersen TI, Paus E, Nesland JM, McKenzie SJ, Børresen AL (1995)
   Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour
   Acta Oncol, 34 (4), 499-504
   PubMed 7605658
2. Berner A, Geitvik G, Karlsen F, Fosså SD, Nesland JM, Børresen AL (1995)
   TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue
   J Pathol, 176 (3), 299-308
   PubMed 7674092
3. Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fosså SD (1995)
   DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma
   Br J Urol, 75 (1), 26-32
   PubMed 7531589
4. Dunsaed CB, Dornish JM, Aastveit TE, Nesland JM, Pettersen EO (1995)
   Growth inhibition of human tumor xenografts in nude mice by treatment with the antitumor agent 4,6-benzylidene-d1-D-glucose (P-1013)
   Anticancer Drugs, 6 (3), 456-64
   PubMed 7670145
5. Helseth A, Haug E, Nesland JM, Siegal GP, Fodstad O, Bautch VL (1995)
   Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors
   J Neurosurg, 82 (5), 879-85
   PubMed 7714615
6. Holm R, Høie J, Kaalhus O, Nesland JM (1995)
   Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland
   Virchows Arch, 427 (3), 289-94
   PubMed 7496599
7. Karlsen F, Steen HB, Nesland JM (1995)
   SYBR green I DNA staining increases the detection sensitivity of viruses by polymerase chain reaction
   J Virol Methods, 55 (1), 153-6
   PubMed 8576305
8. Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simões M, Nesland JM (1995)
   Proliferative activity of synovial sarcoma: an immunohistochemical evaluation of Ki-67 labeling indices of 52 primary and recurrent tumors
   Ultrastruct Pathol, 19 (2), 101-6
   PubMed 7792946
9. Lothe RA, Peltomäki P, Tommerup N, Fosså SD, Stenwig AE, Børresen AL, Nesland JM (1995)
   Molecular genetic changes in human male germ cell tumors
   Lab Invest, 73 (5), 606-14
   PubMed 7474934
10. Lothe RA, Slettan A, Saeter G, Brøgger A, Børresen AL, Nesland JM (1995)
    Alterations at chromosome 17 loci in peripheral nerve sheath tumors
    J Neuropathol Exp Neurol, 54 (1), 65-73
    PubMed 7815081
11. Nilsson A, Farrants AK, Nesland JM, Finstad HS, Pedersen JI (1995)
    Potentiating effects of clofibric acid on the differentiation of HL-60 human promyelocytic leukemia cells induced by retinoids
    Eur J Cell Biol, 67 (4), 379-85
    PubMed 8521878
12. Peng Q, Moan J, Ma LW, Nesland JM (1995)
    Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma
    Cancer Res, 55 (12), 2620-6
    PubMed 7780978
13. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM, Giercksky KE (1995)
    Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma
    Photochem Photobiol, 62 (5), 906-13
    PubMed 8570730
14. Skomedal H, Kristensen G, Helland A, Nesland JM, Kooi S, Børresen AL, Holm R (1995)
    TP53 gene mutations and protein accumulation in primary vaginal carcinomas
    Br J Cancer, 72 (1), 129-33
    PubMed 7599041
15. Skullerud K, Stenwig AE, Brandtzaeg P, Nesland JM, Kerty E, Langmoen I, Saeter G (1995)
    Intracranial primary leiomyosarcoma arising in a teratoma of the pineal area
    Clin Neuropathol, 14 (4), 245-8
    PubMed 8521631
16. Suo Z, Su W, Holm R, Nesland JM (1995)
    Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas
    Anticancer Res, 15 (6B), 2797-8
    PubMed 8669867

Publications 1994

1. Abeler VM, Holm R, Nesland JM, Kjørstad KE (1994)
   Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
   Cancer, 73 (3), 672-7
   PubMed 8299089
2. Berner A, Harvei S, Tretli S, Fosså SD, Nesland JM (1994)
   Prostatic carcinoma: a multivariate analysis of prognostic factors
   Br J Cancer, 69 (5), 924-30
   PubMed 7514029
3. Bjerkehagen B, Fosså SD, Raabe N, Holm R, Nesland JM (1994)
   Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV
   Eur Urol, 26 (4), 334-9
   PubMed 7713133
4. Bjerklund Johansen TE, Majak M, Nesland JM (1994)
   Testicular histology after treatment with the new antiandrogen Casodex for carcinoma of the prostate. A preliminary report
   Scand J Urol Nephrol, 28 (1), 67-70
   PubMed 8009196
5. David L, Nesland JM, Holm R, Sobrinho-Simões M (1994)
   Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients
   Cancer, 73 (3), 518-27
   PubMed 8299074
6. Erlandson RA, Nesland JM (1994)
   Tumors of the endocrine/neuroendocrine system: an overview
   Ultrastruct Pathol, 18 (1-2), 149-70
   PubMed 7910711
7. Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O (1994)
   TP53 allele loss, mutations and expression in malignant melanoma
   Br J Cancer, 69 (2), 253-9
   PubMed 7905277
8. Giercksky KE, Qvist H, Giercksky TC, Warloe T, Nesland JM (1994)
   Multiple glove powder granulomas masquerading as peritoneal carcinomatosis
   J Am Coll Surg, 179 (3), 299-304
   PubMed 8069426
9. Hall WA, Myklebust A, Godal A, Nesland JM, Fodstad O (1994)
   In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma
   Neurosurgery, 34 (4), 649-55; discussion 655-6
   PubMed 8008162
10. Holm R, Nesland JM (1994)
    [Microwave oven in immunohistochemistry. An important tool for determination of antigens in formalin-fixed and paraffin-embedded tissue]
    Tidsskr Nor Laegeforen, 114 (20), 2392-4
    PubMed 7527943
11. Holm R, Nesland JM (1994)
    Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland
    J Pathol, 172 (3), 267-72
    PubMed 8195930
12. Holm R, Tanum G, Karlsen F, Nesland JM (1994)
    Prevalence and physical state of human papillomavirus DNA in anal carcinomas
    Mod Pathol, 7 (4), 449-53
    PubMed 8066073
13. Høie J, Jørgensen OG, Nesland JM, Møller P, Bjøro K (1994)
    [Medullary thyroid carcinoma--familial or sporadic disease?]
    Tidsskr Nor Laegeforen, 114 (25), 2951-4
    PubMed 7974404
14. Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simões M, Nesland JM (1994)
    Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumours, recurrences and metastases
    Pathol Res Pract, 190 (2), 168-77
    PubMed 7520165
15. Makar AP, Holm R, Kristensen GB, Nesland JM, Tropé CG (1994)
    The expression of c-erbB-2 (HER-2/neu) oncogene in invasive ovarian malignancies
    Int J Gynecol Cancer, 4 (3), 194-199
    PubMed 11578406
16. Nesland JM, Børresen AL, Andersson LC (1994)
    [Molecular pathology. A new diagnostic dimension]
    Tidsskr Nor Laegeforen, 114 (26), 3047-8
    PubMed 7974419
17. Reed W, Bryne M, Clausen H, Dabelsteen E, Nesland JM (1994)
    Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions
    Anticancer Res, 14 (2B), 609-15
    PubMed 7516636
18. Rosenberg C, Andersen TI, Nesland JM, Lier ME, Brøgger A, Børresen AL (1994)
    Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques
    Cancer Genet Cytogenet, 75 (1), 1-5
    PubMed 8039157

Publications 1993

1. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen AL (1993)
   Prognostic significance of TP53 alterations in breast carcinoma
   Br J Cancer, 68 (3), 540-8
   PubMed 8102535
2. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL (1993)
   p53 abnormalities in different subtypes of human sarcomas
   Cancer Res, 53 (3), 468-71
   PubMed 8425179
3. Berner A, Danielsen HE, Juul NO, Juul ME, Pettersen EO, Reith A, Nesland JM, Fosså SD (1993)
   Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry
   Anal Cell Pathol, 5 (6), 339-52
   PubMed 8305330
4. Berner A, Danielsen HE, Pettersen EO, Fosså SD, Reith A, Nesland JM (1993)
   DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas
   Anal Quant Cytol Histol, 15 (4), 247-52
   PubMed 7691062
5. Berner A, Jacobsen AB, Fosså SD, Nesland JM (1993)
   Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder
   Histopathology, 22 (4), 327-33
   PubMed 8099896
6. Berner A, Nesland JM, Waehre H, Silde J, Fosså SD (1993)
   Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens
   Br J Cancer, 68 (2), 380-4
   PubMed 7688548
7. Carneiro F, David L, Seruca R, Castedo S, Nesland JM, Sobrinho-Simões M (1993)
   Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family
   Cancer, 72 (2), 323-9
   PubMed 8319165
8. David L, Nesland JM, Funderud S, Sobrinho-Simões M (1993)
   CDw75 antigen expression in human gastric carcinoma and adjacent mucosa
   Cancer, 72 (5), 1522-7
   PubMed 8348485
9. Fosså SD, Berner AA, Jacobsen AB, Waehre H, Kvarstein B, Urnes T, Ogreid P, Johansen TE, Silde J, Nesland JM (1993)
   Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer
   Br J Cancer, 68 (3), 572-8
   PubMed 8102536
10. Gorczyca W, Holm R, Nesland JM (1993)
    Laminin production and fibronectin immunoreactivity in breast carcinomas
    Anticancer Res, 13 (4), 851-8
    PubMed 8394677
11. Helland A, Holm R, Kristensen G, Kaern J, Karlsen F, Trope C, Nesland JM, Børresen AL (1993)
    Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas
    J Pathol, 171 (2), 105-14
    PubMed 8283348
12. Helseth A, Bautch VL, Haug E, Holm R, Nesland JM, Fodstad O (1993)
    [Transgenic mice as animal model of Cushing's syndrome]
    Tidsskr Nor Laegeforen, 113 (2), 206-10
    PubMed 8381565
13. Holm R, Abeler VM, Skomedal H, Nesland JM (1993)
    Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri
    Zentralbl Pathol, 139 (2), 153-6
    PubMed 8103676
14. Holm R, Helseth A, Nesland JM, Bautch VL (1993)
    ACTH-producing pituitary tumors in transgenic mice. An ultrastructural and immunoelectron microscopic study
    J Submicrosc Cytol Pathol, 25 (1), 29-36
    PubMed 8384929
15. Holm R, Skomedal H, Helland A, Kristensen G, Børresen AL, Nesland JM (1993)
    Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri
    J Pathol, 169 (1), 21-6
    PubMed 8433212
16. Horvath G, Baldetorp B, Fernö M, Johansson M, Nesland J, Tropé C (1993)
    Effect of estradiol on tumor growth, cell kinetics and p53 oncoprotein expression in human endometrial adenocarcinoma heterotransplanted into nude mice
    In Vivo, 7 (5), 451-6
    PubMed 8110990
17. Lopes JM, Bjerkehagen B, Sobrinho-Simoes M, Nesland JM (1993)
    The ultrastructural spectrum of synovial sarcomas: a study of the epithelial type differentiation of primary tumors, recurrences, and metastases
    Ultrastruct Pathol, 17 (2), 137-51
    PubMed 8391175
18. Makar AP, Kristensen GB, Nesland J, Børmer OP, Tropé CG (1993)
    Serum CA 125 as a tumor marker and the expression of c-erbB-2 oncogene in tubal malignancies
    Int J Gynecol Cancer, 3 (2), 116-121
    PubMed 11578331
19. Ottestad L, Andersen TI, Nesland JM, Skrede M, Tveit KM, Nustad K, Børresen AL (1993)
    Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis
    Acta Oncol, 32 (3), 289-94
    PubMed 8100712
20. Ottestad L, Pettersen EO, Nesland JM, Hannisdal E, Fosså SD, Tveit KM (1993)
    Flow cytometric DNA analysis as prognostic factor in human breast carcinoma
    Pathol Res Pract, 189 (4), 405-10
    PubMed 8351241
21. Peng Q, Brown SB, Moan J, Nesland JM, Wainwright M, Griffiths J, Dixon B, Cruse-Sawyer J, Vernon D (1993)
    Biodistribution of a methylene blue derivative in tumor and normal tissues of rats
    J Photochem Photobiol B, 20 (1), 63-71
    PubMed 8229471
22. Pettersen EO, Larsen RO, Dornish JM, Børretzen B, Juul ME, Aastveit TE, Nesland JM, Rofstad EK, Oftebro R (1993)
    Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H)
    Br J Cancer, 67 (4), 650-6
    PubMed 8471421
23. Reed W, Erikstein BK, Funderud S, Lilleng R, Tvedt K, Nesland JM (1993)
    CDw75 antigen expression in breast lesions
    Pathol Res Pract, 189 (4), 394-8
    PubMed 7688897
24. Suo Z, Holm R, Nesland JM (1993)
    Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours
    Histopathology, 23 (1), 45-54
    PubMed 7690007
25. Suo Z, Qvist H, Su W, Holm R, Giercksky KE, Nesland JM (1993)
    Undifferentiated carcinoma: an immunohistochemical and ultrastructural study
    Anticancer Res, 13 (3), 643-9
    PubMed 8317892
26. Taccagni G, Sambade C, Nesland J, Terreni MR, Sobrinho-Simões M (1993)
    Solitary fibrous tumour of the thyroid: clinicopathological, immunohistochemical and ultrastructural study of three cases
    Virchows Arch A Pathol Anat Histopathol, 422 (6), 491-7
    PubMed 8333152

Publications 1992

1. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, Børresen AL (1992)
   Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas
   Genes Chromosomes Cancer, 4 (2), 113-21
   PubMed 1373310
2. Børresen AL, Helland A, Nesland J, Holm R, Trope C, Kaern J (1992)
   Papillomaviruses, p53, and cervical cancer
   Lancet, 339 (8805), 1350-1
   PubMed 1350005
3. David L, Nesland JM, Clausen H, Carneiro F, Sobrinho-Simões M (1992)
   Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases
   APMIS Suppl, 27, 162-72
   PubMed 1520525
4. David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Børresen AL, Sobrinho-Simões M (1992)
   c-erbB-2 expression in primary gastric carcinomas and their metastases
   Mod Pathol, 5 (4), 384-90
   PubMed 1353880
5. Holm R, Karlsen F, Nesland JM (1992)
   In situ hybridization with nonisotopic probes using different detection systems
   Mod Pathol, 5 (3), 315-9
   PubMed 1323105
6. Kaern J, Iversen T, Tropé C, Pettersen EO, Nesland JM (1992)
   Flow cytometric DNA measurements in squamous cell carcinoma of the vulva: an important prognostic method
   Int J Gynecol Cancer, 2 (4), 169-174
   PubMed 11576255
7. Lilleng R, Hagmar BM, Nesland JM (1992)
   C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast
   Mod Pathol, 5 (1), 41-7
   PubMed 1347423
8. Logothetou-Rella H, Karayiannis A, Vamvassakis E, Livaditou A, Pikramenos D, Nesland JM, Dimopoulos C (1992)
   A cytologic, ultrastructural and immunocytochemical comparison of tumor cells and cell cultures originating in invasive bladder carcinoma
   Eur Urol, 21 (2), 146-50
   PubMed 1379923
9. Lothe RA, Fossli T, Danielsen HE, Stenwig AE, Nesland JM, Gallie B, Børresen AL (1992)
   Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors
   J Natl Cancer Inst, 84 (14), 1100-8
   PubMed 1619684
10. Nesland JM, Grude TH, Ottestad L, Johannessen JV (1992)
    Invasive lobular carcinoma of the breast. The importance of an alveolar growth pattern
    Pathol Annu, 27 Pt 1, 233-47
    PubMed 1736244
11. Peng Q, Moan J, Warloe T, Nesland JM, Rimington C (1992)
    Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma
    Int J Cancer, 52 (3), 433-43
    PubMed 1399120
12. Reed W, Gundersen S, Lønning PE, Nesland JM (1992)
    [Prognostic parameters in localized breast cancer]
    Tidsskr Nor Laegeforen, 112 (6), 757-9
    PubMed 1561596
13. Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobrinho-Simões M, Børresen AL (1992)
    P53 mutations in gastric carcinomas
    Br J Cancer, 65 (5), 708-10
    PubMed 1586599
14. Sund BS, Topstad TK, Nesland JM (1992)
    A case of juvenile papillomatosis of the male breast
    Cancer, 70 (1), 126-8
    PubMed 1606534
15. Suo Z, Holm R, Nesland JM (1992)
    Squamous cell carcinomas, an immunohistochemical and ultrastructural study
    Anticancer Res, 12 (6B), 2025-31
    PubMed 1284199
16. Vergote I, De Vos L, Fjeld J, Nesland J, Kierulf B, Michaelsen T, Nustad K (1992)
    B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production
    Hybridoma, 11 (3), 323-31
    PubMed 1500068
17. Vergote I, Larsen RH, de Vos L, Nesland JM, Bruland O, Bjørgum J, Alstad J, Tropé C, Nustad K (1992)
    Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model
    Gynecol Oncol, 47 (3), 366-72
    PubMed 1473751

Publications 1991

1. Abeler VM, Kjørstad KE, Nesland JM (1991)
   Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases
   Cancer, 68 (1), 98-105
   PubMed 2049761
2. Berner A, Nesland JM (1991)
   Endocrine profile in gastric carcinomas. An immunohistochemical study
   Histol Histopathol, 6 (3), 317-23
   PubMed 1725759
3. Børresen AL, Hovig E, Smith-Sørensen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ, Friend SH (1991)
   Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations
   Proc Natl Acad Sci U S A, 88 (19), 8405-9
   PubMed 1924299
4. Fosså SD, Nesland JM, Pettersen EO, Amellem O, Waehre H, Heimdal K (1991)
   DNA ploidy in primary testicular cancer
   Br J Cancer, 64 (5), 948-52
   PubMed 1931622
5. Fosså SD, Nesland JM, Waehre H, Amellem O, Pettersen EO (1991)
   DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I
   Cancer, 67 (7), 1874-7
   PubMed 1848470
6. Jebsen PW, Hagmar BM, Nesland JM (1991)
   Metaplastic breast carcinoma. A diagnostic problem in fine needle aspiration biopsy
   Acta Cytol, 35 (4), 396-402
   PubMed 1718111
7. Nesland JM (1991)
   [The mitochondrium--a fascinating organelle]
   Tidsskr Nor Laegeforen, 111 (2), 176
   PubMed 1705367
8. Nesland JM (1991)
   [p53--a gene to mark itself]
   Tidsskr Nor Laegeforen, 111 (22), 2721-2
   PubMed 1948860
9. Nesland JM, Ottestad L, Børresen AL, Tvedt KE, Holm R, Heikkilä R, Tveit K (1991)
   The c-erbB-2 protein in primary and metastatic breast carcinomas
   Ultrastruct Pathol, 15 (3), 281-9
   PubMed 1678562
10. Nesland JM, Ottestad L, Heikilla R, Holm R, Tveit K, Børresen AL (1991)
    C-erbB-2 protein and neuroendocrine expression in breast carcinomas
    Anticancer Res, 11 (1), 161-7
    PubMed 1673329
11. Peng Q, Farrants GW, Madslien K, Bommer JC, Moan J, Danielsen HE, Nesland JM (1991)
    Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line
    Int J Cancer, 49 (2), 290-5
    PubMed 1879972
12. Rofstad EK, Wahl A, Hystad ME, Nesland JM, Stokke T (1991)
    Establishment in monolayer culture and characterization of four human melanoma cell lines
    Virchows Arch B Cell Pathol Incl Mol Pathol, 60 (3), 189-97
    PubMed 1679270

Publications 1990

1. Berner A, Børmer O, Marton PF, Nesland JM (1990)
   Distribution of the carcinoembryonic antigen CEA in gastric lesions. Immunohistochemical testing of three novel monoclonal antibodies
   Histol Histopathol, 5 (2), 199-204
   PubMed 2134373
2. Børresen AL, Ottestad L, Gaustad A, Andersen TI, Heikkilä R, Jahnsen T, Tveit KM, Nesland JM (1990)
   Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis
   Br J Cancer, 62 (4), 585-90
   PubMed 1977466
3. Fosså SD, Nesland JM, Melvik JE, Jacobsen AB, Moe B (1990)
   Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma
   Acta Oncol, 29 (3), 303-6
   PubMed 2363942
4. Jacobsen AB, Nesland JM, Fosså SD, Pettersen EO (1990)
   Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma
   J Urol, 143 (4), 706-9
   PubMed 2313795
5. Kjønniksen I, Nesland JM, Pihl A, Fodstad O (1990)
   Nude rat model for studying metastasis of human tumor cells to bone and bone marrow
   J Natl Cancer Inst, 82 (5), 408-12
   PubMed 2304088
6. Logothetou-Rella H, Nesland JM, Kipiotis D, Paraschou E, Sechas M, Varonos DD (1990)
   Canine capillary formation in vitro
   Histol Histopathol, 5 (1), 55-64
   PubMed 2134356
7. Nesland JM (1990)
   The c-erB-2 protein
   Ultrastruct Pathol, 14 (5), iii-iv
   PubMed 1978949
8. Peng Q, Moan J, Nesland JM, Rimington C (1990)
   Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts
   Int J Cancer, 46 (4), 719-26
   PubMed 2210887
9. Peng Q, Nesland JM, Moan J, Evensen JF, Kongshaug M, Rimington C (1990)
   Localization of fluorescent Photofrin II and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light-sensitive video intensification microscopy
   Int J Cancer, 45 (5), 972-9
   PubMed 2139867
10. Rofstad EK, Wahl A, Stokke T, Nesland JM (1990)
    Establishment and characterization of six human melanoma xenograft lines
    APMIS, 98 (10), 945-53
    PubMed 2245014
11. Sobrinho-Simoes M, Sambade C, Nesland JM, Holm R, Damjanov I (1990)
    Lectin histochemistry and ultrastructure of medullary carcinoma of the thyroid gland
    Arch Pathol Lab Med, 114 (4), 369-75
    PubMed 1690976

Publications 1989

1. Abeler V, Nesland JM (1989)
   Alveolar soft-part sarcoma in the uterine cervix
   Arch Pathol Lab Med, 113 (10), 1179-83
   PubMed 2802951
2. Dasovi?-Knezevi? M, Børmer O, Holm R, Høie J, Sobrinho-Simões M, Nesland JM (1989)
   Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies
   Mod Pathol, 2 (6), 610-7
   PubMed 2587568
3. Falkmer S, Askensten U, Nesland JM (1989)
   Tumour pathology of the neuron-paraneuron system and its evolutionary background, with special attention to neuro-endocrine differentiation in prostate and mammary carcinomas
   Arch Histol Cytol, 52 Suppl, 225-32
   PubMed 2510784
4. Holm R, Farrants GW, Nesland JM, Sobrinho-Simões M, Jørgensen OG, Johannessen JV (1989)
   Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma
   Virchows Arch A Pathol Anat Histopathol, 414 (5), 375-84
   PubMed 2499093
5. Holm R, Nesland JM, Attramadal A, Halse J, Johannessen JV (1989)
   Null cell adenomas of the pituitary gland. An immunohistochemical study
   J Pathol, 158 (3), 213-7
   PubMed 2769482
6. Holm R, Nesland JM, Attramadal A, Reinli S, Johannessen JV (1989)
   Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study
   J Submicrosc Cytol Pathol, 21 (2), 339-50
   PubMed 2752363
7. Johansen TE, Clausen OP, Nesland JM (1989)
   The effect of non-union of testis and epididymis and of cryptorchidism on the development of epididymis and ductus deferens in the rat
   Andrologia, 21 (5), 441-8
   PubMed 2573293
8. Kota?ska KM, Holm R, Ottestad L, Nesland JM (1989)
   An ultrastructural study of benign and malignant breast epithelial cells. A search for tonofilaments
   J Submicrosc Cytol Pathol, 21 (3), 469-74
   PubMed 2551480
9. Logothetou-Rella H, Kotoulas IG, Nesland JM, Kipiotis D, Abazis D (1989)
   Early human trophoblast cell cultures. A morphological and immunocytochemical study
   Histol Histopathol, 4 (3), 367-74
   PubMed 2520471
10. Nesland JM, Johannessen JV (1989)
    In situ hybridization
    Ultrastruct Pathol, 13 (1), iii
    PubMed 2465641
11. Ottestad L, Tveit KM, Hannisdal E, Skrede M, Nesland JM, Gundersen S, Pihl A (1989)
    Colony forming ability of human breast carcinomas: lack of prognostic significance
    Br J Cancer, 60 (2), 216-9
    PubMed 2765368
12. Saeter G, Schwarze PE, Nesland JM, Seglen PO (1989)
    Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells
    Br J Cancer, 59 (2), 198-205
    PubMed 2930686
13. Sambade C, Sarabando F, Nesland JM, Sobrinho Simões M (1989)
    Hyalinizing trabecular adenoma of the thyroid (case of the Ullensvang course). Hyalinizing spindle cell tumor of the thyroid with dual differentiation (variant of the so-called hyalinizing trabecular adenoma)
    Ultrastruct Pathol, 13 (2-3), 275-80
    PubMed 2734856
14. Seglen PO, Skomedal H, Saeter G, Schwarze PE, Nesland JM (1989)
    Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours
    Carcinogenesis, 10 (1), 21-5
    PubMed 2910524
15. Sobrinho-Simões M, Sambade C, Nesland JM, Johannessen JV (1989)
    Tall cell papillary carcinoma
    Am J Surg Pathol, 13 (1), 79-80
    PubMed 2909201

Publications 1988

1. Abeler V, Kjørstad KE, Nesland JM (1988)
   Small cell carcinoma of the ovary. A report of six cases
   Int J Gynecol Pathol, 7 (4), 315-29
   PubMed 2852647
2. Erikstein B, Nesland JM, Ottestad L, Lund E, Johannessen JV (1988)
   Neuron specific enolase-positive breast carcinomas
   Histol Histopathol, 3 (1), 97-102
   PubMed 2980214
3. Fodstad O, Kjønniksen I, Aamdal S, Nesland JM, Boyd MR, Pihl A (1988)
   Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells
   Cancer Res, 48 (15), 4382-8
   PubMed 3390834
4. Fodstad O, Aamdal S, McMenamin M, Nesland JM, Pihl A (1988)
   A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX
   Int J Cancer, 41 (3), 442-9
   PubMed 3346110
5. Holm R, Nesland JM, Attramadal A, Johannessen JV (1988)
   Double-staining methods at the ultrastructural level applying colloidal gold conjugates
   Ultrastruct Pathol, 12 (3), 279-90
   PubMed 2456636
6. Johansen TE, Clausen OP, Nesland JM (1988)
   A comparative study of the effects of non-union of testis and epididymis and cryptorchidism on testicular development and spermatogenesis in the rat
   Andrologia, 20 (3), 189-201
   PubMed 2902815
7. Logothetou-Rella H, Nesland JM, Karayiannis A, Dimopoulos C (1988)
   Growth characteristics of cultured human normal bladder epithelial cells: a comparison with urothelial carcinoma cell cultures
   Eur Urol, 15 (3-4), 259-63
   PubMed 3215260
8. Logothetou-Rella H, Nesland JM, Vamvassakis E, Karayiannis A, Hadjiminas J, Dimopoulos C (1988)
   Common characteristics of primary cell cultures originated from invasive urothelial carcinoma
   Eur Urol, 14 (1), 61-4
   PubMed 3342808
9. Logothetou-Rella H, Vamvassakis E, Nesland JM, Hadjiminas J, Dimopoulos C (1988)
   Morphological and immunohistochemical characteristics of a cell line originated from noninvasive human bladder transitional-cell carcinoma
   Eur Urol, 14 (1), 65-71
   PubMed 3342809
10. Nesland JM, Holm R, Johannessen JV, Gould VE (1988)
    Neuroendocrine differentiation in breast lesions
    Pathol Res Pract, 183 (2), 214-21
    PubMed 3290869
11. Nesland JM, Holm R, Ottestad L, Karlsen KO, Johannessen JV (1988)
    Neuroendocrine activity in metastatic breast carcinomas
    APMIS Suppl, 2, 204-14
    PubMed 2846016
12. Ottestad L, Tveit KM, Høifødt HK, Nesland JM, Vaage S, Høie J, Lund E, Pihl A (1988)
    Cultivation of human breast carcinoma in soft agar. Experience with 237 fresh tumour specimens
    Br J Cancer, 58 (1), 8-12
    PubMed 3048354
13. Ottestad LO, Tveit KM, Nesland JM, Dybsjord I, Børmer O, Høie J, Pihl A (1988)
    An immunocytochemical method for assaying oestrogen receptors in breast cancers. A comparison with the steroid binding assay
    Histol Histopathol, 3 (3), 269-74
    PubMed 2980233
14. Saeter G, Schwarze PE, Nesland JM, Juul N, Pettersen EO, Seglen PO (1988)
    The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas
    Carcinogenesis, 9 (6), 939-45
    PubMed 3370757
15. Saeter G, Schwarze PE, Nesland JM, Seglen PO (1988)
    2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism
    Carcinogenesis, 9 (4), 581-7
    PubMed 2895691
16. Sobrinho-Simões M, Nesland JM, Johannessen JV (1988)
    Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid
    Am J Clin Pathol, 89 (2), 264-7
    PubMed 3341287
17. Sobrinho-Simões M, Nesland JM, Johannessen JV (1988)
    What's going on in nerve sheath tumors?
    Ultrastruct Pathol, 12 (1), iii-iv
    PubMed 3354069

Publications 1987

1. Bjerkås I, Nesland JM (1987)
   Brain and spinal cord lesions in encephalitozoonosis in the blue fox
   Acta Vet Scand, 28 (1), 15-22
   PubMed 3120524
2. Holm R, Sobrinho-Simões M, Nesland JM, Sambade C, Johannessen JV (1987)
   Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity?
   Lab Invest, 57 (3), 258-68
   PubMed 3626517
3. Lunde S, Nesland JM, Holm R, Johannessen JV (1987)
   A urinary bladder tumor in a 65-year-old man
   Ultrastruct Pathol, 11 (1), 79-82
   PubMed 3824568
4. Lunde S, Nesland JM, Holm R, Johannessen JV (1987)
   Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study
   Pathol Res Pract, 182 (5), 627-31
   PubMed 2825146
5. Nesland JM, Holm R, Lunde S, Johannessen JV (1987)
   Diagnostic problems in breast pathology: the benefit of ultrastructural and immunocytochemical analysis
   Ultrastruct Pathol, 11 (2-3), 293-311
   PubMed 3035768
6. Nesland JM, Lunde S, Holm R, Johannessen JV (1987)
   Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells
   Histol Histopathol, 2 (1), 73-7
   PubMed 2980706
7. Nesland JM, Sobrinho-Simoes M, Johannessen JV (1987)
   Scanning electron microscopy of the human thyroid gland and its disorders
   Scanning Microsc, 1 (4), 1797-810
   PubMed 3433063
8. Saeter G, Schwarze PE, Nesland JM, Seglen PO (1987)
   Transplantation of preneoplastic rat hepatocytes by intraportal injection
   Toxicol Pathol, 15 (1), 78-81
   PubMed 3554470
9. Sobrinho-Simões M, Nesland JM, Johannessen JV (1987)
   Thyroid antibodies
   Am J Surg Pathol, 11 (10), 821-4
   PubMed 3661825

Publications 1986

1. Eker R, Nesland JM, Andersen A, Johannessen JV (1986)
   Prognostic factors in renal cell carcinoma
   Histol Histopathol, 1 (3), 255-70
   PubMed 2980119
2. Fodstad O, Brøgger A, Bruland O, Solheim OP, Nesland JM, Pihl A (1986)
   Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma
   Int J Cancer, 38 (1), 33-40
   PubMed 3459716
3. Holm R, Sobrinho-Simões M, Nesland JM, Johannessen JV (1986)
   Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells
   Ultrastruct Pathol, 10 (3), 241-8
   PubMed 3715999
4. Kjellevold K, Nesland JM, Holm R, Johannessen JV (1986)
   Multicystic peritoneal mesothelioma
   Pathol Res Pract, 181 (6), 767-73
   PubMed 2436202
5. Lunde S, Nesland JM, Holm R, Johannessen JV (1986)
   Primary malignant fibrous histiocytoma of the breast
   Histol Histopathol, 1 (1), 27-32
   PubMed 2856533
6. Nesland JM, Holm R, Johannessen JV (1986)
   A study of different markers for neuroendocrine differentiation in breast carcinomas
   Pathol Res Pract, 181 (5), 524-30
   PubMed 2431399
7. Nesland JM, Holm R, Johannessen JV (1986)
   Spindle cell tumor in the breast
   Ultrastruct Pathol, 10 (5), 415-9
   PubMed 2429416
8. Nesland JM, Holm R, Johannessen JV, Gould VE (1986)
   Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations
   J Pathol, 148 (1), 35-43
   PubMed 3003312
9. Nesland JM, Holm R, Sund BS, Johannessen JV (1986)
   A thyroid tumor in a 57-year-old man
   Ultrastruct Pathol, 10 (2), 197-202
   PubMed 3515708
10. Nesland JM, Pettersen EO, Fosså SD, Høie J, Johannessen JV (1986)
    Nuclear DNA content in breast carcinomas with neuroendocrine differentiation
    J Pathol, 150 (3), 181-5
    PubMed 3027292
11. Pettersen EO, Schwarze PE, Dornish JM, Nesland JM (1986)
    Antitumour effect of benzylidene-glucose (BG) in rats with chemically induced hepatocellular carcinoma
    Anticancer Res, 6 (2), 147-52
    PubMed 3707050
12. Rode L, Nesland JM, Johannessen JV (1986)
    A spindle cell breast lesion in a 54-year-old woman
    Ultrastruct Pathol, 10 (5), 421-5
    PubMed 2429417
13. Sobrinho-Simões M, Stenwig AE, Nesland JM, Holm R, Johannessen JV (1986)
    A mucinous carcinoma of the thyroid
    Pathol Res Pract, 181 (4), 464-71
    PubMed 3020530

Publications 1985

1. Holm R, Sobrinho-Simões M, Nesland JM, Gould VE, Johannessen JV (1985)
   Medullary carcinoma of the thyroid gland: an immunocytochemical study
   Ultrastruct Pathol, 8 (1), 25-41
   PubMed 3901454
2. Nesland JM, Holm R, Johannessen JV (1985)
   Ultrastructural and immunohistochemical features of lobular carcinoma of the breast
   J Pathol, 145 (1), 39-52
   PubMed 2578561
3. Nesland JM, Johannessen JV (1985)
   Spindle cell tumor of the ovary
   Ultrastruct Pathol, 8 (4), 363-8
   PubMed 3001986
4. Nesland JM, Memoli VA, Holm R, Gould VE, Johannessen JV (1985)
   Breast carcinomas with neuroendocrine differentiation
   Ultrastruct Pathol, 8 (2-3), 225-40
   PubMed 4060259
5. Nesland JM, Sobrinho-Simões MA, Holm R, Johannessen JV (1985)
   Organoid tumor in the thyroid gland
   Ultrastruct Pathol, 9 (1-2), 65-70
   PubMed 4089997
6. Nesland JM, Sobrinho-Simões MA, Holm R, Johannessen JV (1985)
   Primitive neuroectodermal tumor (peripheral neuroblastoma)
   Ultrastruct Pathol, 9 (1-2), 59-64
   PubMed 3003993
7. Nesland JM, Sobrinho-Simões MA, Holm R, Sambade MC, Johannessen JV (1985)
   Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry
   Ultrastruct Pathol, 8 (4), 269-90
   PubMed 4082297
8. Sobrinho-Simões M, Nesland JM, Johannessen JV (1985)
   Farewell to the dual histogenesis of thyroid tumors?
   Ultrastruct Pathol, 8 (2-3), iii-v
   PubMed 2865835
9. Sobrinho-Simões M, Nesland JM, Johannessen JV (1985)
   The mystery of the anemone cell tumor
   Ultrastruct Pathol, 8 (4), iii-iv
   PubMed 4082296
10. Sobrinho-Simões MA, Nesland JM, Holm R, Johannessen JV (1985)
    Transmission electron microscopy and immunocytochemistry in the diagnosis of thyroid tumors
    Ultrastruct Pathol, 9 (3-4), 255-75
    PubMed 3911530
11. Sobrinho-Simões MA, Nesland JM, Holm R, Sambade MC, Johannessen JV (1985)
    Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study
    Ultrastruct Pathol, 8 (2-3), 131-42
    PubMed 4060255
12. Sobrinho-Simões MA, Nesland JM, Johannessen JV (1985)
    A mucin-producing tumor in the thyroid gland
    Ultrastruct Pathol, 9 (3-4), 277-81
    PubMed 4090007
13. Aamdal S, Fodstad O, Nesland JM, Pihl A (1985)
    Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice
    Br J Cancer, 51 (3), 347-56
    PubMed 3970811

Publications 1984

1. Aguiar A, Sobrinto-Simões MM, Finseth I, Johannessen JV, Nesland JM (1984)
   Uncombable hair
   Arch Dis Child, 59 (1), 92-3
   PubMed 6696511
2. Kjellevold KH, Finseth I, Nesland JM (1984)
   Collar button nuclei
   Ultrastruct Pathol, 6 (2-3), 255-8
   PubMed 6087529
3. Nesland JM, Johannessen JV (1984)
   Scanning electron microscopy of the human breast and its disorders
   J Submicrosc Cytol, 16 (2), 349-57
   PubMed 6325723
4. Nesland JM, Johannessen JV (1984)
   Small cell tumor in a 24-year-old male
   Ultrastruct Pathol, 6 (4), 341-6
   PubMed 6485124
5. Nesland JM, Kjellevold K, Finseth I, Fodstad O (1984)
   Spherical bodies
   Ultrastruct Pathol, 7 (1), 73-8
   PubMed 6097001
6. Nesland JM, Langholm R, Marton PF (1984)
   Hexagonal crystals in the bone marrow in patients with myeloproliferative disease and preleukaemia
   Scand J Haematol, 32 (5), 552-8
   PubMed 6328640
7. Wibe E, Berg JP, Tveit KM, Nesland JM, Lunde S (1984)
   Multicellular spheroids grown directly from human tumour material
   Int J Cancer, 34 (1), 21-6
   PubMed 6746116

Publications 1983

1. Nesland JM, Høie J, Johannessen JV (1983)
   The fine structure of the human breast and its benign disorders
   Diagn Histopathol, 6 (2), 51-67
   PubMed 6319095

Publications 1982

1. Nesland JM, Johannessen JV (1982)
   Malignant breast lesions
   J Submicrosc Cytol, 14 (3), 553-75
   PubMed 6294315
2. Nesland JM, Millonig G, Wilson A, Johannessen JV (1982)
   Rapid techniques in diagnostic electron microscopy
   Ultrastruct Pathol, 3 (3), 295-300
   PubMed 6183809

Publications 1981

1. Nesland JM, Olafsson J, Sobrinho-Simöes M (1981)
   Plasmacytoid myoepithelioma of the palate
   J Oral Pathol, 10 (1), 14-21
   PubMed 6259307
2. Sobrinho-Simões M, Nesland JM, Johannessen JV (1981)
   Diagnostic ultrastructural pathology--sub-speciality or special stain?
   Diagn Histopathol, 4 (3), 223-36
   PubMed 7273994

Publications 1980

1. Solheim LF, Hagen R, Nesland JM (1980)
   [Synovial chondromatosis of the ankle joint]
   Tidsskr Nor Laegeforen, 100 (28), 1666-7
   PubMed 7444912
2. Solheim LF, Wennberg JE, Nesland JM (1980)
   Granular cell myoblastoma of the hands. Report of a child with multiple tumors
   Arch Orthop Trauma Surg, 97 (3), 231-2
   PubMed 6255894